Abeona Therapeutics Inc. Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2020

Components of lease cost are as follows:

	For the three months ended March 31,
	2020		2019
Operating lease cost	$	434,000	$	289,000
Variable lease cost	$	83,000	$	73,000
Short-term lease cost	$	18,000	$	47,000

The following table presents information about the amount and timing of cash flows arising from operating leases as of March 31, 2020:

Maturity of lease liabilities:
2020, remainder	$	1,275,000
2021		1,713,000
2022		1,727,000
2023		1,741,000
2024		1,781,000
Thereafter		1,885,000
Total undiscounted operating lease payments		10,122,000
Less: imputed interest		2,407,000
Present value of operating lease liabilities	$	7,715,000

Balance sheet classification:
Current portion of lease liability	$	1,702,000
Long-term lease liability		6,013,000
Total operating lease liabilities	$	7,715,000

Other information:
Weighted-average remaining lease term for operating leases	70 months
Weighted-average discount rate for operating leases		9.6	%